Medical outcomes
CVD
CVD, NON-ALCOHOLIC FATTY LIVER DISEASE, HYPERTENSION, TYPE 2 DIABETES, DYSLIPIDEMIA
We will access participant medical records to extract breast cancer diagnostic and treatment information and for chemotherapy outcomes (relative dose intensity, chemotherapy dose reductions and delays). We will also assess incident diagnoses of cardiometabolic conditions (hypertension, dyslipidemia, type 2 diabetes, CVD and non-alcoholic fatty liver disease) at the 2-year follow-up.